Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levcromakalim and glibenclamide effect on cranial arteries
NCT03886922Unknown
- Sponsor
- Dansk Hovedpinecenter
- Start
- Apr 2019
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of glibenclamide in migraine, sponsored by Dansk Hovedpinecenter. Status: unknown.
02
Drugs
glibenclamide
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03886922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03886922.